For 454, Roche s Cash Came Just in Time; Solexa Considers Different Tack | GenomeWeb

NEW YORK, Nov. 14 (GenomeWeb News) - While the potential market for next-generation sequencing technologies is estimated to be at least $1 billion today, that doesn't mean companies developing products are having an easy time raising money to bring their product to market. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.